Pleural mesothelioma: Long-term progression-free survival with Tumor Treating Fields (TTFields) therapy case reports

被引：0
|
作者：
Ceresoli, Giovanni Luca [1 ]
Mannarino, Laura [2 ,3 ]
Paracchini, Lara [2 ,3 ]
Grosso, Federica [4 ]
机构：
[1] Humanitas Gavazzeni, Dept Med Oncol, Oncol Unit, Bergamo, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] IRCCS Humanitas Res Hosp, Lab Canc Pharmacol, Milan, Italy
[4] SS Antonio & Biagio Gen Hosp, Mesothelioma & Rare Canc Unit, Alessandria, Italy
来源：
CURRENT PROBLEMS IN CANCER: CASE REPORTS | 2025年 / 17卷
关键词：
PHASE-III; GLIOBLASTOMA;
D O I：
10.1016/j.cpccr.2024.100342
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma
    van de Velde, Helgi J. K.
    Liu, Xiangyang
    Chen, Gang
    Cakana, Andrew
    Deraedt, William
    Bayssas, Martine
    HAEMATOLOGICA, 2007, 92 (10) : 1399 - 1406
  • [22] A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor
    Mollica, Veronica
    Di Nunno, Vincenzo
    Corcioni, Beniamino
    Fiorentino, Michelangelo
    Nobili, Elisabetta
    Schiavina, Riccardo
    Golfieri, Rita
    Brunocilla, Eugenio
    Ardizzoni, Andrea
    Massari, Francesco
    ANTI-CANCER DRUGS, 2018, 29 (09) : 911 - 913
  • [23] Long-term survival of patients diagnosed with malignant pleural mesothelioma
    Batchelor, TJP
    Wallace, T
    Trotter, M
    Mearns, AJ
    Anikin, V
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2004, 86 (02) : 133 - 133
  • [24] Long-term outcomes in the PRIMA trial: a closer look at progression-free survival and overall survival
    Wu, T.
    Zhang, P.
    Wang, G.
    ANNALS OF ONCOLOGY, 2025, 36 (03) : 340 - 340
  • [25] Association of tumor treating fields (TTFields) therapy with overall survival in newly diagnosed glioblastoma
    Shah, Siddharth
    Nag, Aiswarya
    Lucke-Wold, Brandon
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [26] Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case Report
    Velasco, Marisa Torres
    Gallego, Rafael Alvarez
    Peinado, Paloma
    Gregorio, Cesar Munoz
    Ugidos, Lisardo
    Morillo, Marcial Garcia
    Vicente, Emilio
    Quijano, Yolanda
    Prados, Susana
    de la Fuente, Enrique
    Gracian, Antonio Cubillo
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 843 - 851
  • [27] GENETIC MARKERS CORRELATED WITH PROGRESSION-FREE SURVIVAL TIMES IN GLIOBLASTOMA PATIENTS UNDERGOING TREATMENT WITH TUMOR TREATING FIELDS
    Monson, Caitlin
    Tipps, Megan
    Jackson, Kelsey
    Tierney, Meghan
    Banerji, Nilanjana
    Trusheim, John
    NEURO-ONCOLOGY, 2020, 22 : 10 - 10
  • [28] Long-Term Progression-Free Survival in a Patient with Locally Advanced, Unresectable Pancreatic Adenocarcinoma
    Dyer, Brandon A.
    Kahn, Leonel A.
    Matin, Mahan
    Bold, Richard J.
    Tanaka, Michael I.
    Monjazeb, Arta M.
    CUREUS, 2015, 7 (12):
  • [29] Long term survival after trimodal therapy in malignant pleural mesothelioma
    Fahrner, Rene
    Ochsenbein, Adrian
    Schmid, Ralph A.
    Carboni, Giovanni L.
    SWISS MEDICAL WEEKLY, 2012, 142
  • [30] Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review
    Zhang, Di
    Huang, Jiaqi
    Sun, Yulan
    Guo, Qisen
    ONCOTARGETS AND THERAPY, 2019, 12 : 3635 - 3644
12345